Navigation Links
New Vascular Access Medical Devices Launched by Navilyst Medical
Date:9/11/2008

Navilyst Medical, the manufacturer and global marketer of vascular access and fluid management medical devices, has launched new products just four weeks after the company's introduction of its new corporate brand following the previously announced divestiture from Boston Scientific. They are: 1) an Expanded PICC Convenience Kit program , 2) the inudstry's only dual-safety EZ Huber® Infusion Needle Set; and 3) new Xcela® Power Injectable Ports. The two new devices and enhanced PICC Convenience Kitting offerings expand Navilyst Medical's popular vascular access device product lines and can contribute to a hospital's infection prevention program. The products are designed to contribute to a hospital's compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals.

Marlborough, MA (PRWEB) September 11, 2008 -- Navilyst Medical, the manufacturer and global marketer of vascular access and fluid management medical devices, today announced its first in a series of new product launches as the company's newly branded entity. These new products are being debuted just four weeks after the company's introduction of its new corporate brand, following the previously announced divestiture from Boston Scientific. The products are designed to contribute to a hospital's compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals.

The two new devices and enhanced PICC Convenience Kitting offerings expand Navilyst Medical's popular vascular access device product lines and can contribute to a hospital's infection prevention program. The new products will be premiered at Booth #202 at Annual Scientific Meeting of the Association for Vascular Access (AVA) in Savannah, Georgia this week.
http://www.n
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. MAQUET Cardiovascular Responds to Terumo Complaint About VASOVIEW Endoscopic Vessel Harvesting Systems
2. Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
3. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
4. Navilyst Medical Announces Global Debut Today : Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets
5. New discovery may lead to immunization against cardiovascular disease
6. Geneva Offers First Cardiovascular Technology Graduate Program in the Nation
7. Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies
8. Vascular Solutions CEO Elected to MDMA Board of Directors
9. Leading worldwide cause of cardiovascular disease may be modified by diet
10. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
11. Building a Fully Integrated Cardiovascular Imaging and Information System Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vascular Access Medical Devices Launched by Navilyst Medical
New Vascular Access Medical Devices Launched by Navilyst Medical
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...earchers at the University of Warwick have discove...e the onset of early diabetic kidney disease. , K...rogressively in patients with type 2 diabetes. Ear...a. , The research is led by Dr Naila Rabbani and ...
...NSOCKET, R.I., Dec. 8 Fulfilling a commitment to ...flu shot, CVS/pharmacy, the,nation,s largest retai...ealth,care clinic in the U.S., announced that they...mark Corp. (NYSE: CVS ), launched,an integrated ...
... FRANCISCO ― Age alone should not determine ...ia or myelodysplastic syndrome receives a blood st...rs of the Center for International Blood and Marro... younger patients with transplants that are preced...
...SNO, Calif., Dec. 8 Over 56% of American Dietetic... concerned that the current,economic downturn will... to,maintain or achieve a healthy weight, accordin...expressed concern that the economic downturn would...
...HA, Neb., Dec. 8 Deaconess Hospital has entered a... Inc . to offer its Medicare-eligible patients acc...Medicare Advantage and Part D prescription drug pl...a, UnitedHealthcare, Coventry, CIGNA, Aetna, Pyram...
...ERLY HILLS, Calif., Dec. 8 The Lap Band or the,ad...vasive operation used as,an alternative medical we...ls.,Studies show with the FDA approval in 2001; La...s,the stomach smaller so that you eat less. It wor...
Other Medicine News:Health News:Vitamin B1 could reverse early-stage kidney disease in diabetes patients 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 3Health News:Older age doesn't affect survival after bone marrow transplant 2Health News:Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets. 2Health News:Deaconess Hospital Partners With Senior Market Sales to Expand Insurance Offering for Medicare-Eligible Patients 2Health News:Lap Band - Approximately 33 Percent of Adults in America are Obese LAP BAND Surgery Can Improve Your Life 2Health News:Lap Band - Approximately 33 Percent of Adults in America are Obese LAP BAND Surgery Can Improve Your Life 3
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 1TrinityCare Senior Living Announces Expansion into Louisiana 57948 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 3Moroney 26 Gill Inc Launches New Website 57946 1Cynosure to Present at the Maxim Group Growth Conference 57944 1Cynosure to Present at the Maxim Group Growth Conference 57944 2
...iency and quality to routine urine microscopic ana...orescent flow cytometry with fully automated urine...ocessing are easily accommodated by the rack-based...igh volume laboratories. Fluorescent flow cytomet...
... incorporates a translucent inner sleeve into a pr... each needle load matches the proper load configur...dle options, the IsoSleeve™ system allows fo... giving you confidence that the needle load is cor...
...ish streaking machine. It will load, streak and st.... Automated streaking results in substantial cost ...tivity, improves isolation rates, standardizes str...A filtered personnel protection. In total, over 1/...
Acquidata Uromac Petite Urodynamics System
Medicine Products: